Haemochromatosis in the new millennium

Journal of Hepatology

Volumn 32, Issue SUPPL.1, 2000, Pages 48-62

  Powell, Lawrie W ^a   Subramaniam, V Nathan ^b   Yapp, Thomas R ^b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b NONE

Author keywords

Haemochromatosis; HFE; Iron overload; Population screening

Indexed keywords

FERRITIN; IRON;

AMINO ACID SUBSTITUTION; CHROMOSOME 6; CORONARY ARTERY DISEASE; GENE LOCATION; GENETIC SCREENING; GENOTYPE; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; IRON BINDING CAPACITY; IRON INTAKE; IRON METABOLISM; IRON OVERLOAD; LIVER BIOPSY; LIVER CELL CARCINOMA; MISSENSE MUTATION; PHENOTYPE; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; REVIEW;

ANIMALS; ENVIRONMENT; GASTROENTEROLOGY; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MEMBRANE PROTEINS; MUTATION;

EID: 0034092719     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80415-8     Document Type: Article

References (116)

1. Trousseau A. Glycosurie, diabete sucre. In: Anonymous Clinique medicale de l'Hotel-Dieu de Paris. 2 edn. Paris: Balliere; 1865. p. 663.
2. von Recklinghausen FD. Taggeblet der (62) Versainumlung Deutsch Naturforsch Arzt Heidelberg 1889: 324-5.
3. Sheldon JH. Haemochromatosis. London: Oxford University Press; 1935. p. 382.
4. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6: 24-9.
5. Scheuer PJ, Williams R., Muir AR. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol 1962; 84: 53-64.
6. Ludwig J, Hashimoto E, Porayko MK, et al. Hemosiderosis in cirrhosis: A study of 447 native livers. Gastroenterology 1997; 112: 882-8.
7. Cotler SJB, Bronner MP, Press RD, et al. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol 1998; 29: 257-62.
8. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class-I like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408.
9. Powell LW, Leggett BA, Crawford DHG. Hemochromatosis and other iron storage disorders. In: Schiff ER, Sorrell MF, Maddrey WC, editors. Schiff's Diseases of the Liver, 8th edn. Philadelphia: Lippincott-Raven; 1998.
10. Milman N. Hereditary haemochromatosis in Denmark 1950-1985: clinical, biochemical and histological features in 179 patients and 13 preclinical cases. Dan Med Bull 1991; 38: 385-93.
11. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997; 25: 162-6.
12. Olynyk J, Digby J, Cullen DJ, et al. A population based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341: 718-24.
13. Lamon JM, Marynick SP, Roseblatt R, Donnelly S. Idiopathic hemochromatosis in a young female. A case study and review of the syndrome in young people. Gastroenterology 1979; 76: 178-83.
14. Felts JH, Nelson JR, Herndon CN, Spurr CL. Hemochromatosis in two young sisters. Case studies and a family survey. Ann Intern Med 1967; 67: 117-23.
15. Charlton RW, Abrahams C, Bothwell TH. Idiopathic hemochromatosis in young subjects. Clinical, pathological, and chemical findings in four patients. Arch Pathol 1967; 83: 132-40.
16. Cazzola M, Ascari E, Claudiani G, et al. Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet 1983; 65: 149-54.
17. Camaschella C, Cicilano M, Bosio S, et al. Juvenile and adult hemochromatosis are distinct genetic disorders. Eur J Hum Genet 1997; 5: 371-5.
18. Roetto A, Totaro A, Cazzola M, et al. Juvenile hemochromatosis locus maps to chromosome 1q. Am J Hum Genet 1999; 64: 1388-93.
19. Knisely AS, Magid MS, Dische MR, Cutz E. Neonatal hemochromatosis. Birth Defects 1987; 23: 75-102.
20. Witzelbin CL, Uri A. Perinatal hemochromatosis: entity or end result? Hum Pathol 1989; 20: 335-40.
21. Silver MM, Beverley DW, Valberg LS, et al. Perinatal hemochromatosis: clinical morphologic and quantitative iron studies. Am J Pathol 1987; 128: 538-54.
22. Verloes A, Temple IK, Hubert A-F, et al. Recurrence of neonatal haemochromatosis in half sibs born of unaffected mothers. J Med Genet 1996; 33: 444-9.
23. Rand EB, McClenathan DT, Whitington PF. Neonatal hemochromatosis: report of successful orthotopic liver transplantation. J Pediatr Gastroenterol Nutr 1992; 15: 325-9.
24. Knisely AS. Neonatal hemochromatosis. Adv Pediatrics 1992; 39: 383-403.
25. MacDonald RA. Hemochromatosis and hemosiderosis. Springfield, IL: C Thomas; 1964.
26. Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA A3 and HLA B14 antigens with idiopathic hemochromatosis. Gut 1976; 17: 332-4.
27. Walters JM, Watt DW, Stevens FM, McCarthy CF. HLA antigens in haemochromatosis. Br Med J 1975; 4: 520.
28. Simon M, Alexandre JL, Bourel M, LeMarec B, Scordia C. Heredity of idiopathic hemochromatosis: a study of 106 families. Clin Genet 1977; 11: 327-41.
29. Doran T, Bashir HV, Trejaut J, Bassett ML, Halliday JW, Powell LW. Idiopathic hemochromatosis in the Australian population: HLA linkage and recessivity. Human Immunol 1981; 2: 191-200.
30. Ritter B, Safwenberg J, Olsson KS. HLA as a marker of the hemochromatosis gene in Sweden. Hum Genet 1984; 68: 62-6.
31. Summers KM, Tam KS, Halliday JW, Powell LW HLA determinants in an Australian population of hemochromatosis patients and their families. Am J Hum Genet 1989; 45: 41-8.
32. Santos M, Schilham MW, Rademakers LPHM, Marx JJM, De Sousa M, Clevers H. Defective iron homeostasis in Beta2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. J Exp Med 1996; 184: 1975-85.
33. Rothenberg BE, Voland JR. Beta-2-microglobulin knockout mice develop parenchymal iron overload: a putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci USA 1996; 93: 1529-34.
34. Carella M, D'Ambrosio L, Totaro A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997; 60: 828-32.
35. Jazwinska EC, Cullen LM, Busfield F, et al. Haemochromatosis and HLA-H [letter]. Nat Genet 1996; 14: 249-51.
36. Jouanolle AM, Gandon G, Jezequel P, et al. Haemochromatosis and HLA-H. Nat Genet 1996; 14: 251-2.
37. Worwood M, Shearman JD, Wallace DF, et al. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 1997; 41: 841-4.
38. Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 1999; 116: 193-207.
39. Pietrangelo A, Montosi G, Totaro A, et al. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N Engl J Med 1999; 341: 725-32.
40. Wallace DF, Dooley JS, Walker AP. A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote. Gastoenterology 1999; 116: 1409-12.
41. Mura C, Raguenes O, Ferec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 1999; 93: 2502-5.
42. Edwards CQ, Griffin LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988; 318: 1355-62.
43. Leggett BA, Halliday JW, Brown NN, Bryant S, Powell LW. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 1990; 74: 525-30.
44. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJH. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275-8.
45. Cullen LM, Summerville L, Glassick TV, Crawford DHG, Powell LW, Jazwinska EC. Neonatal screening for the haemochromatosis defect. Blood 1997; 90: 4236-7.
46. Rochette J, Pointon JJ, Fisher CA, et al. Multicentric origin of HFE mutations. Am J Hum Genet 1999; In press.
47. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997; 349: 321-3.
48. Sampietro M, Piperno A, Lupica L, et al. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria curtanea tarda. Hepatology 1998; 27: 181-4.
49. Stuart KA, Busfield F, Jazwinska EC, et al. The C282Y mutation in haemochromatosis (HFE) gene and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. J Hepatol 1998; 28: 404-9.
50. Villiers JN, Hillermann R, Loubser L, Kotze MJ. Spectrum of mutations in the HFE gene implication in haemochromatosis and porphyria. Hum Mol Genet 1999; 8: 1517-22.
51. George DK, Goldwurm S, Macdonald GA, et al. Increased hepatic iron stores on non alcoholic steatohepatitis are associated with the hemochromatosis mutation and increased liver damage. Gastroenterology 1998; 114: 311-8.
52. Turlin B, Juguet F, Moirand R, et al. Increased liver iron stores in patients with hepatocellular carcinoma developed on a non-cirrhotic liver. Hepatology 1995; 22: 446-50.
53. Deugnier YM, Charalambous R Le Quilleuc D, et al. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients. Hepatology 1993; 18: 1363-9.
54. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981; 1293-4.
55. Lauffer RB. Iron stores and the international variation in mortality from coronary artery disease. Med Hypotheses 1990; 35: 96-102.
56. Smith BC, Grove J, Guzail MA, et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 1998; 27: 1695-9.
57. Barton JC, Harmon L, Rivers C, Acton RT. Hemochromatosis: association of severity of iron overload with genetic markers. Blood Cells Molecules Dis 1996; 22: 195-204.
58. Crawford DH, Halliday JW, Summers KM, Bourke MJ, Powell LW. Concordance of iron storage in siblings with genetic hemochromatosis: evidence for a predominantly genetic effect on iron storage. Hepatology 1993; 17: 833-7.
59. Muir WA, McLaren GD, Braun W, Askari A. Evidence for heterogeneity in hereditary hemochromatosis. Evaluation of 174 persons in nine families. Am J Med 1984; 76: 806-14.
60. Adams PC. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes. Am J Hematol 1994; 45: 146-9.
61. Bulaj ZJ, Griffen BA, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996; 335: 1799-805.
62. Borot N, Roth M, Malfroy L, et al. Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients. Immunogenetics 1997; 45: 320-4.
63. Sham RL, Ou CY, Cappuccio J, Braggins C, Dunnigan K, Phatak PD. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases. Blood Cells Molecules Dis 1997; 23: 314-20.
64. Crawford DH, Powell LW, Leggett BA, et al. Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene. Am J Hum Genet 1995; 57: 362-7.
65. Crawford DHG, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous subjects for the C282Y mutation. Gastroenterology 1998; 114: 1003-8.
66. Parkkila S, Waheed A, Britton RS, et al. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastroentestinal tract. Proc Natl Acad Sci USA 1997; 94: 2534-9.
67. Sanchez M, Queralt R, Bruguera M, Rodes J, Oliva R. Cloning, sequencing and characterisation of the rat hereditary hemochromatosis promoter: comparison of the human, mouse and rat HFE promoter regions. Gene 1998; 255: 77-87.
68. Cox TM, Peters T. Uptake of iron by duodenal biopsy specimens from patients with iron deficiency anaemia and primary haemochromatosis. Lancet 1978; i: 123-4.
69. Raja KB, Pountney D, Bomford A, et al. A duodenal mucosal abnormality in the reduction of Fe(III) in patients with genetic haemochromatosis. Gut 1996; 38: 765-9.
70. Powell LW, Campbell CB, Wilson E. Intestinal mucosal uptake of iron and iron retention in idiopathic hemochromatosis as evidence of a mucosal abnormality. Gut 1970; 11: 727-31.
71. Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998; 1472-7.
72. Roy CN, Penny DM, Feder JN, Enns CA. The hereditary hemochromatosis protein, HFE, specifically regulates transferrin-mediated iron uptake in HeLa cells. J Biol Chem 1999; 274: 9022-8.
73. Waheed A, Parkkila S, Saarnio J, et al. Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci USA 1999; 96: 1579-84.
74. Gross CN, Irrinki A, Feder JN, Enns CA. Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein with the transferrin receptor implies a role in intracellular iron regulation. J Biol Chem 1998; 273: 22068-74.
75. Salter-Cid L, Brunmark A, Li Y, et al. Transferrin receptor is negatively modulated by the hemochromatosis protein HFE: implications for cellular iron homeostasis. Proc Nat Acad Sci USA 1999; 96: 5434-9.
76. Lebron JA, Bjorkman PJ. The transferrin receptor binding site on HFE, the class I MHC-related protein mutated in hereditary hemochromatosis. J Mol Biol 1999; 289: 1109-18.
77. Fleming M, Trenor C, Su M, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997; 16: 383-6.
78. Gunshin H, Mackenzie B, Berger U, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388: 482-8.
79. Hentze MW, Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric-oxide, and oxidative stress. Proc Natl Acad Sci USA 1996; 93: 8175-82.
80. Sciot R, Paterson AC, Van Den Oord JJ, Desmet VJ. Lack of hepatic transferrin receptor expression in hemochromatosis. Hepatology 1987; 7: 831-7.
81. Lombard M, Bomford A, Hynes M, et al. Regulation of the hepatic transferrin receptor in hereditary hemochromatosis. Hepatology 1989; 9: 1-5.
82. Pietrangelo A, Rocchi E, Rigo G, et al. Regulation of transferrin, transferrin receptor and ferritin gene expression in the duodenum of normal anemic and siderotic subjects. Gastroenterology 1992; 102: 802-9.
83. Vulpe CD, Kuo YM, Murphy TL, et al. Hephastin, a ceruloplasmin homologue implicated in intestinal iron transportion, is defective in the sla mouse. Nat Genet 1999; 21: 195-9.
84. Britton RS, Bacon BR, Recknagel RO. Lipid peroxidation and associated hepatic organelle dysfunction in iron overload. Chem Phys Lipids 1987; 45: 207-39.
85. Tavill AS, Sharma BK, Bacon BR. Iron and the liver: genetic hemochromatosis and other hepatic iron overload disorders. Prog Liver Dis 1990; 9: 281-305.
86. Young IS, Trouton TG, Torney JJ, McMaster D, Callendar ME, Trimble ER. Genetic hemochromatosis and Wilson's Disease: Role for oxidant stress? Free Rad Biol Med 1994; 16: 393-7.
87. Stocker R. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Curr Opin Lipidol 1994; 5: 422-33.
88. Ramm GA, Halliday JW, Fletcher LM, Walker NJ, Powell LW, Crawford DHG. Hepatic stellate cell activation in genetic hemochromatosis: lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol 1997; 26: 584-92.
89. Houglum K, Bedossa P, Chojkier M. TGF-B and collagen-a1 (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload. Am J Physiol 1994; 5: G908-G913.
90. Houglum K, Filip M, Witztum JL, Chojkier M. Malondialdehyde and 4-hydroxynoneal protein adducts in plasma and liver of rats with iron overload. J Clin Invest 1990; 86: 1991-8.
91. Houglum K, Lee KS, Chojkier M. Proliferation of hepatic stellate cells is inhibited by phosphorylation of CREB on serine 133. J Clin Invest 1997; 99: 1322-8.
92. Houglum K, Ramm GA, Crawford DHG, et al. Excess iron induces hepatic transforming growth factor Betal in genetic hemochromatosis: role of oxidative stress. Hepatology 1997; 27: 605-10.
93. Houglum K. Alcohol and iron: A radical combination? Hepatology 1996; 23: 1700-3.
94. Beutler E. The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 1997; 61: 762-4.
95. Jeffrey GP, Chakrabarti S, Hegele RA, Adams PC. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis. Nat Genet 1999; 22: 325-6.
96. Beutler E. Genetic irony beyond haemochromatosis: clinical effect of HLA-H mutations. Lancet 1997; 349: 296-7.
97. Martinez PA, Biron C, Blanc F, et al. Compound heterozygotes for hemochromatosis gene mutations: may they help to understand the pathophysiology of the disease? Blood Cells Molecules Dis 1997; 23: 269-76.
98. Risch R. Haemochromatosis, HFE and genetic complexity. Nat Genet 1997; 17: 375-6.
99. Lebron JA, Bennett MJ, Vaughn DE, et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998; 93: 111-23.
100. Waheed A, Parkkila S, Zhou XY, et al. Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with Beta2-microglobulin, intracellular processing and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA 1997; 94: 12384-9.
101. Parkkila S, Waheed A, Britton RS, et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 1997; 94: 13198-202.
102. Anderson GJ, Powell LW, Halliday JW1. Transferrin receptor distribution and regulation in the rat small intestine: Effect of iron stores and erythropoiesis. Gastroenterology 1990; 98: 576-85.
103. Banerjee D, Flanagan PR, Cluett J, Valberg LS. Transferrin receptors in the human gastrointestinal tract. Relationship to body iron stores. Gastroenterology 1986; 91: 861-9.
104. Bassett ML, Halliday JW, Powell LW. Genetic hemochromatosis. Semin Liver Dis 1997; 4: 217-27.
105. Guyader D, Jacquelinet C, Moirand R, et al. Non-invasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998; 115: 929-36.
106. Adams PC. Implications of genotyping of spouses to limit investigation of children in genetic hemochromatosis. Clin Genet 1998; 53: 176-8.
107. McLaren C, McLachlan G, Halliday J, et al. The distribution of transferrin saturation in an asymptomatic Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology 1998; 114: 543-9.
108. Wilson JMG, Junger G. Principles and practice of screening for disease. Public Health Papers WHO 1986; 26-39.
109. Hickman P, Hourigan L, Powell LW, Crawford DHG. Automated measurement of unsaturated iron binding capacity allows a cost effective, ongoing strategy for screening for haemochromatosis. Hepatology 1998; 28: 422A.
110. Adams PC, Valberg LS. Screening blood donors for hereditary hemochromatosis: decision analysis model comparing genotyping to phenotyping. Am J Gastroenterol 1999; 94: 1593-600.
111. Yapp TR, Eijkelkamp EJ, Powell LW. HFE-associated haemochromatosis in subjects aged 30 years or younger. Hepatology (in press) 1999; [Abstract].
112. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-19.
113. Niederau C, Fisher R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313: 1256-62.
114. Dixon JL, Do K-A, Fargion S, Conte D, Losowsky MS, Powell LW. Effectiveness of regular surveillance for hepatocellular carcinoma in haemochromatosis with cirrhosis. Hepatology 1998; 28 (Pt 2):421A.
115. Eason RJ, Adams PC, Aston CE, Searle J. Familial iron overload with possible autosomal dominant inheritance. Aust NZ J Med 1990; 20: 226-30.
116. Eijkelkamp EJ, Yapp TR, Powell LW. HFE associated hereditary haemochromatosis. Can J Gastroenterol 1999; (in press).